Prostate Cancer
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib - Abstract
April 20, 2011
No evidence of XMRV in prostate cancer cohorts in the Midwestern United States - Abstract
April 20, 2011
Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California - Abstract
April 20, 2011
PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40! - Abstract
April 20, 2011
Effect of urologists and medical oncologists on treatment of elderly men with stage IV prostate cancer - Abstract
April 19, 2011
Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men - Abstract
April 19, 2011
Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? - Abstract
April 19, 2011
The short-term use of erythropoetin-stimulating agents: Impact on the biochemical recurrence of prostate cancer - Abstract
April 19, 2011